Horizon Therapeutics Dividend yield

Horizon Therapeutics is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Horizon Therapeutics is a company from USA, and his stocks are publicly traded.

Horizon Therapeutics stock dividend

Horizon Therapeutics paid a total dividend of 0 million USD last year, for a market value of 24,775 millions (Market Cap 24,112 millions). Horizon Therapeutics dividend per share is 0.00 USD, and his stock market price 109.14 USD.

According to the chart below where dividend yield is displayed, Horizon Therapeutics, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Horizon Therapeutics might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Horizon Therapeutics stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest USA dividend stocks list.

Horizon Therapeutics Dividend Payout

About the ability of Horizon Therapeutics to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Horizon Therapeutics payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Horizon Therapeutics, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Horizon Therapeutics Dividend History

Below you will find a table with the historical evolution of Horizon Therapeutics's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	0.00%	0.00	0.00%	227
2022	0.00%	0.00	0.00%	227

*In millions

Horizon Therapeutics Stock performance

Finally, last moth Horizon Therapeutics showed a return of -0.30% compared to a worldwide -0.50% average, and a 1.27% of Health Care firms. Over the last year, the company obtained a 3.70% versus a worldwide performance of a -2.10%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.